Edited by Peter Hillerberg1 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
The biggest insider sell logged in recent filings belongs to CPAY Chairman and CEO Ronald Clarke. He filed $209.5 million worth of Corpay sales across 15 trades between August 21 and August 25. That is a concentrated burst of selling, even by executive standards.
MSFT CEO Satya Nadella also filed sales totalling around $52.7 million between August 31 and September 1. TPC Executive Chairman Ronald Tutor filed $196.8 million in sales on August 31, spread across two transactions, as did SNDK CEO David Goeckeler who reported $73.7 million in sales filed August 27.
On the buy side, the most striking pattern comes from outside the US. Shenzhou International Group Holdings () Executive Chairman Ma Jianrong filed four consecutive open-market purchases between September 1 and September 4, totalling roughly $51.4 million. He bought into a stock that JPMorgan was simultaneously reducing, with the bank filing a $19.9 million sale on September 8. That divergence, a chairman buying as an institutional holder exits, is worth watching.
Closer to home, NGL Director John Raymond filed a $5.1 million purchase on August 26, one of the few clear discretionary US buys in the period.
Medicare Advantage penetration reached a record 51.1% in June 2026 per ORTEX Alt Data, a structural tailwind that may partly explain insider confidence in healthcare-adjacent names. The broad labour market backdrop looks firm too, with US nonfarm payrolls hitting a record 159,044 thousand in September 2026.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
